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The National Animal Health 
Monitoring Systems Dairy 2007 study 
indicates that 68.1 percent of U.S. 
dairy operations are infected with 
Mycobacterium avium subspecies 
paratuberculosis (MAP), the organism 
that causes Johne’s disease. The 
2007 NAHMS study also suggests 
that at least one in four U.S. dairy 
operations may have a relatively high 
percentage of Johne’s-infected cows 
in their herds. 
There are three stages of Johne’s 
disease in cattle: 
 STAGE I: Cattle are infected 
but showing no clinical signs and not 
shedding MAP. 
Typically this stage occurs in 
calves, heifers, and young stock less 
than two years of age and many adult 
animals exposed to small doses of the 
disease-causing organism. This stage 
progresses slowly over many months 
or years to Stage II. 
 STAGE II: Cattle are infected, 
shedding MAP but do not show clinical 
signs of the disease. 
Typically this stage occurs in older 
heifers or adults. These animals pose 
a major, but often hidden, threat for 
infection of other animals through 
contamination of the environment. 
 STAGE III: Cattle are shedding 
MAP and showing clinical signs. 
The onset of Stage III is often 
associated with a period of stress, 
such as recent calving. Cattle at 
this stage have intermittent, watery 
manure. Animals lose weight and 
gradually drop in milk production but 
continue to have a good appetite. 
 
Some animals appear to recover but 
often relapse in the next stress period. 
Most of these animals are shedding 
billions of MAP organisms that can 
infect herdmates and calves.  
In the fi nal and terminal aspects 
of Stage III of the fatal disease, 
animals become emaciated with fl uid 
diarrhea and develop “bottle jaw.” The 
carcass may not pass meat inspection 
for human consumption in the later 
phases of Stage III. 
‘The Iceberg Phenomenon’ – 
In the typical herd, for every 
animal showing clinical signs (Stage 
III), many other cattle are present in 
the earlier stages of the disease. The 
clinical case represents only the “tip of 
the iceberg” of the Johne’s infection.
For every Stage III cow expect: 
1-2 more cows in Stage III 
(clinically diseased)
6-8 cows in Stage II (unapparent 
shedders)
10-15 cows in Stage I (infected but 
not shedding MAP)
Researchers contend that, in a 
herd of 100 milking cows, two clinical 
cases at one time suggest 20-30 
others are infected, and less than half 
of the infected cattle are detectable by 
fecal culture. If 25-30 animals are fecal 
culture positive on a 
single test in a herd of 
100 adult cattle, it is 
likely that at least 50 
percent of the cattle 
(or 50 animals) in the 
herd are infected. 
The iceberg 
phenomenon 
illustrates   the 
key concept in 
recognizing the 
potential impact that 
Johne’s disease can 
have on a herd. That 
is, if the infection 
remains unchecked, 
the rate and number 
of infected animals 
in the herd increases 
progressively over 
time. Early diagnosis and prevention 
of spread, before clinical cases have 
surfaced, can avoid the development 
of Johne’s disease into a signifi cant 
herd problem fi ve to ten years into   
the future.
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 Johne’s disease researchers 
and experts have long known that 
the bacteria that causes Johne’s 
disease—Mycobacterium avium ssp. 
Paratuberculosis, commonly referred 
to as MAP—has a negative impact on 
dairy reproduction and often leads to 
culling, even early culling.
 Additional research in this area 
confi rms and quantifi es the negative 
impact of Johne’s disease on dairy 
reproduction. The results of the 
research were published in the 
August 2010 issue of the Journal 
of Dairy Science, Vol. 93, Issue 8, 
Pages 3513-3524. Researchers were 
R.L. Smith, R.L. Stawdermant, Y.H. 
Schukkent, S.J. Wells, A.K. Pradhant, 
L.A. Espejo, R.H. Whitlock, J.S. Van 
Kessell, J.M. Smith, D.R. Wolfgang 
and Y.T. Grhon.
To better understand the 
implications of MAP infections and 
Johne’s disease in a dairy herd, the 
researchers calculated the rates of 
calving and culling for cows in each 
stage of MAP infection relative to 
uninfected cows. 
With a strong interest among many 
producers and veterinarians to have a 
more effective vaccine to help protect 
against Johne’s disease, USDA/
APHIS/VS is funding a vaccine project 
overseen by the Johne’s Disease 
Integrated Program. The fi rst phase of 
the project was an in vitro screening of 
all submitted candidates in laboratories 
at the University of Wisconsin-Madison 
and the University of Minnesota. Phase 
2, which has begun, is to evaluate 
the Top 10 candidates using a mouse 
model.
  The top candidates identifi ed in 
Phase 2 will then be evaluated using a 
goat model.
 “The goat model provides results 
very similar to those expected from 
cattle, but they are obtained more 
New Research Quantifi es Negative Impact 
of Johne’s Disease on Reproduction
Data from six commercial dairy 
herds—involving 2,818 cows with 
2,754 calvings and 1,483 cullings—
were used for analysis.
Cows in each study herd were 
individually tested on a regular basis 
for MAP, and herds were followed for 
four to seven years. 
Johne’s disease status, test-
negative, low-positive (low-shedding 
or ELISA-positive only) or high-shedding 
was defi ned as a time-dependent 
variable for all cows with at least one 
positive test result or two negative 
test results.
Research results show that non-
shedding animals were signifi cantly 
less likely to be culled in comparison 
with animals in the low-shedding or 
ELISA-positive category.
The researchers also observed 
an increased calving interval in 
animals shedding high levels of MAP 
compared with low-positive animals.
Vaccine Project in Phase 2
rapidly and at a lower cost,” states Dr. 
Ken Olson, JDIP Outreach Coordinator.
 “It is anticipated that, at the end 
of this process, one or more vaccine 
candidates will be identifi ed for 
potential commercial development.”
 Dr. Olson adds that the project, 
from start to fi nish, is expected to take 
approximately three years.
Editor’s Note: Commonly referred 
to as JDIP, the Johne’s Disease 
Integrated Program is a comprehensive 
consortium of scientists whose mission 
is to promote animal biosecurity 
through the development and support 
of projects designed specifi cally 
to enhance knowledge, promote 
education, develop real-world solutions 
and mitigate losses associated with 
Johne’s Disease. The coming together 
of scientists promotes effi ciencies 
through collaborative research and 
sharing the intellectual and physical 
resources that are critical to overall 
success.
To learn more about the cost of Johne’s disease to dairy producers, send an email to 
info@johnesdisease.org and ask for your free copy of the 16-page “Cost of Johne’s 
Disease to Dairy Producers” booklet.
For information about 
Johne’s disease, 
contact your Designated 
Johne’s Coordinator 
Randy L. Wheeler, 
Randy.Wheeler@IowaAgriculture.gov,  
Ph (515) 281-0866 
or visit 
www.johnesdisease.org
